| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 3.34e-06 | 2 | 37 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 3.34e-06 | 2 | 37 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.00e-05 | 3 | 37 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.90e-05 | 86 | 37 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.28e-04 | 140 | 37 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.36e-04 | 54 | 37 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 1.49e-04 | 10 | 37 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.28e-04 | 303 | 37 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.51e-04 | 167 | 37 | 4 | GO:0031490 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 3.46e-04 | 15 | 37 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.61e-04 | 739 | 37 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | p53 binding | 3.90e-04 | 77 | 37 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 4.46e-04 | 17 | 37 | 2 | GO:0070411 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 4.80e-04 | 775 | 37 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 5.35e-04 | 562 | 37 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 6.86e-04 | 21 | 37 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat modifying activity | 8.25e-04 | 23 | 37 | 2 | GO:0140994 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 9.75e-04 | 417 | 37 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.11e-03 | 1459 | 37 | 9 | GO:0000977 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.50e-03 | 31 | 37 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.14e-03 | 37 | 37 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.41e-03 | 753 | 37 | 6 | GO:0008134 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.91e-03 | 1356 | 37 | 8 | GO:0060090 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 4.02e-03 | 51 | 37 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 4.17e-03 | 582 | 37 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 4.66e-03 | 55 | 37 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 4.82e-03 | 372 | 37 | 4 | GO:0061630 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 4.87e-03 | 1160 | 37 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 4.97e-03 | 187 | 37 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 5.53e-03 | 60 | 37 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 6.11e-03 | 398 | 37 | 4 | GO:0061659 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 6.50e-03 | 206 | 37 | 3 | GO:0140030 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 6.65e-03 | 66 | 37 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 6.65e-03 | 66 | 37 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 7.10e-03 | 1244 | 37 | 7 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.96e-03 | 1271 | 37 | 7 | GO:0000987 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 9.18e-03 | 78 | 37 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 9.64e-03 | 238 | 37 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.03e-02 | 83 | 37 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.06e-02 | 84 | 37 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 1.11e-02 | 473 | 37 | 4 | GO:0004842 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 1.45e-02 | 512 | 37 | 4 | GO:0019787 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.53e-02 | 102 | 37 | 2 | GO:0016410 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | PAXIP1 TRERF1 MED15 ZNF384 HNF1B CHD7 USF3 TOX CREBBP CCNK MEF2C EP300 BRD4 SMAD5 TOX3 | 5.68e-09 | 1390 | 37 | 15 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 8.78e-06 | 423 | 37 | 7 | GO:0002696 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 1.29e-05 | 449 | 37 | 7 | GO:0050867 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.87e-05 | 4 | 37 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell lineage commitment | 2.31e-05 | 31 | 37 | 3 | GO:0043373 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell lineage commitment | 2.79e-05 | 33 | 37 | 3 | GO:0002363 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 2.81e-05 | 338 | 37 | 6 | GO:0045165 | |
| GeneOntologyBiologicalProcess | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 3.34e-05 | 35 | 37 | 3 | GO:0043369 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 5.16e-05 | 999 | 37 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 5.80e-05 | 385 | 37 | 6 | GO:0051251 | |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 5.81e-05 | 42 | 37 | 3 | GO:0002360 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell lineage commitment | 8.71e-05 | 8 | 37 | 2 | GO:2000330 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 9.49e-05 | 421 | 37 | 6 | GO:0048638 | |
| GeneOntologyBiologicalProcess | positive T cell selection | 1.17e-04 | 53 | 37 | 3 | GO:0043368 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 1.24e-04 | 54 | 37 | 3 | GO:0032968 | |
| GeneOntologyBiologicalProcess | embryo development | 1.60e-04 | 1437 | 37 | 10 | GO:0009790 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 1.67e-04 | 906 | 37 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell lineage commitment | 1.70e-04 | 11 | 37 | 2 | GO:2000328 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.73e-04 | 911 | 37 | 8 | GO:0048589 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 1.87e-04 | 62 | 37 | 3 | GO:0032786 | |
| GeneOntologyBiologicalProcess | face development | 1.96e-04 | 63 | 37 | 3 | GO:0060324 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.98e-04 | 929 | 37 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | 2.02e-04 | 694 | 37 | 7 | GO:0002694 | |
| GeneOntologyBiologicalProcess | regulation of sarcomere organization | 2.41e-04 | 13 | 37 | 2 | GO:0060297 | |
| GeneOntologyBiologicalProcess | T cell selection | 2.57e-04 | 69 | 37 | 3 | GO:0045058 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 2.68e-04 | 70 | 37 | 3 | GO:0060261 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell differentiation | 2.81e-04 | 14 | 37 | 2 | GO:2000321 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 3.16e-04 | 336 | 37 | 5 | GO:0071560 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 3.35e-04 | 186 | 37 | 4 | GO:0006367 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | 3.40e-04 | 756 | 37 | 7 | GO:0050865 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 3.48e-04 | 343 | 37 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 3.55e-04 | 77 | 37 | 3 | GO:2000144 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 3.70e-04 | 16 | 37 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 3.70e-04 | 16 | 37 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 4.12e-04 | 81 | 37 | 3 | GO:0060260 | |
| GeneOntologyBiologicalProcess | positive regulation of cell fate commitment | 4.70e-04 | 18 | 37 | 2 | GO:0010455 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 5.79e-04 | 91 | 37 | 3 | GO:2000142 | |
| GeneOntologyBiologicalProcess | modulation by host of symbiont process | 5.79e-04 | 91 | 37 | 3 | GO:0051851 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 6.15e-04 | 596 | 37 | 6 | GO:0001701 | |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 6.17e-04 | 93 | 37 | 3 | GO:0034243 | |
| GeneOntologyBiologicalProcess | T-helper 17 cell lineage commitment | 7.07e-04 | 22 | 37 | 2 | GO:0072540 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 7.19e-04 | 614 | 37 | 6 | GO:0051249 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 7.57e-04 | 231 | 37 | 4 | GO:0006352 | |
| GeneOntologyBiologicalProcess | organelle assembly | 7.71e-04 | 1138 | 37 | 8 | GO:0070925 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 7.74e-04 | 23 | 37 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | P-body assembly | 7.74e-04 | 23 | 37 | 2 | GO:0033962 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 7.74e-04 | 23 | 37 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 7.74e-04 | 23 | 37 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 type immune response | 7.74e-04 | 23 | 37 | 2 | GO:2000318 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 8.07e-04 | 235 | 37 | 4 | GO:0002822 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 8.33e-04 | 237 | 37 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 8.47e-04 | 238 | 37 | 4 | GO:0048639 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 8.78e-04 | 105 | 37 | 3 | GO:0032784 | |
| GeneOntologyBiologicalProcess | cognition | 8.99e-04 | 423 | 37 | 5 | GO:0050890 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 9.01e-04 | 242 | 37 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | chromatin organization | 9.37e-04 | 896 | 37 | 7 | GO:0006325 | |
| GeneOntologyBiologicalProcess | platelet formation | 9.90e-04 | 26 | 37 | 2 | GO:0030220 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 1.00e-03 | 249 | 37 | 4 | GO:0035264 | |
| GeneOntologyBiologicalProcess | leukocyte activation | 1.01e-03 | 1186 | 37 | 8 | GO:0045321 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 1.05e-03 | 252 | 37 | 4 | GO:0002819 | |
| GeneOntologyBiologicalProcess | T-helper cell lineage commitment | 1.07e-03 | 27 | 37 | 2 | GO:0002295 | |
| GeneOntologyBiologicalProcess | head development | 1.09e-03 | 919 | 37 | 7 | GO:0060322 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 1.15e-03 | 28 | 37 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | platelet morphogenesis | 1.15e-03 | 28 | 37 | 2 | GO:0036344 | |
| GeneOntologyBiologicalProcess | positive regulation of mitotic cell cycle phase transition | 1.20e-03 | 117 | 37 | 3 | GO:1901992 | |
| GeneOntologyBiologicalProcess | melanocyte differentiation | 1.23e-03 | 29 | 37 | 2 | GO:0030318 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 1.23e-03 | 29 | 37 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation | 1.26e-03 | 119 | 37 | 3 | GO:0043367 | |
| GeneOntologyBiologicalProcess | growth | 1.31e-03 | 1235 | 37 | 8 | GO:0040007 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | 1.36e-03 | 1242 | 37 | 8 | GO:0002684 | |
| GeneOntologyBiologicalProcess | DNA damage response | 1.39e-03 | 959 | 37 | 7 | GO:0006974 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper cell differentiation | 1.41e-03 | 31 | 37 | 2 | GO:0045624 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.46e-03 | 276 | 37 | 4 | GO:0007179 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 1.51e-03 | 475 | 37 | 5 | GO:0140694 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 1.52e-03 | 127 | 37 | 3 | GO:0006368 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | 1.54e-03 | 976 | 37 | 7 | GO:0046649 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 1.56e-03 | 1269 | 37 | 8 | GO:0009887 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell differentiation | 1.60e-03 | 33 | 37 | 2 | GO:2000319 | |
| GeneOntologyBiologicalProcess | cellular response to light stimulus | 1.63e-03 | 130 | 37 | 3 | GO:0071482 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.79e-03 | 35 | 37 | 2 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.79e-03 | 35 | 37 | 2 | GO:0030511 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 1.79e-03 | 35 | 37 | 2 | GO:0032816 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with symbiont | 1.81e-03 | 135 | 37 | 3 | GO:0051702 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.85e-03 | 136 | 37 | 3 | GO:0030518 | |
| GeneOntologyBiologicalProcess | response to radiation | 1.94e-03 | 503 | 37 | 5 | GO:0009314 | |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 1.09e-04 | 9 | 37 | 2 | GO:0008024 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 4.58e-04 | 18 | 37 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | transcription regulator complex | 5.73e-04 | 596 | 37 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | carboxy-terminal domain protein kinase complex | 8.21e-04 | 24 | 37 | 2 | GO:0032806 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 3.08e-07 | 5 | 17 | 3 | HP:0009715 | |
| HumanPheno | Epididymal neoplasm | 3.08e-07 | 5 | 17 | 3 | HP:0030421 | |
| HumanPheno | Sporadic | 6.10e-07 | 103 | 17 | 6 | HP:0003745 | |
| HumanPheno | Plantar crease between first and second toes | 1.05e-05 | 2 | 17 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.05e-05 | 2 | 17 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 1.05e-05 | 2 | 17 | 2 | HP:0001042 | |
| HumanPheno | Square face | 1.68e-05 | 16 | 17 | 3 | HP:0000321 | |
| HumanPheno | Abnormality of the incisor | 1.97e-05 | 108 | 17 | 5 | HP:0000676 | |
| HumanPheno | Laryngeal cartilage malformation | 3.14e-05 | 3 | 17 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 3.14e-05 | 3 | 17 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 3.14e-05 | 3 | 17 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 3.14e-05 | 3 | 17 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 3.14e-05 | 3 | 17 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 3.14e-05 | 3 | 17 | 2 | HP:0005895 | |
| HumanPheno | Trichiasis | 6.27e-05 | 4 | 17 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 6.27e-05 | 4 | 17 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 6.27e-05 | 4 | 17 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 6.27e-05 | 4 | 17 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 6.27e-05 | 4 | 17 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 6.27e-05 | 4 | 17 | 2 | HP:0031207 | |
| HumanPheno | Shawl scrotum | 6.79e-05 | 25 | 17 | 3 | HP:0000049 | |
| HumanPheno | Abnormal ureter physiology | 9.21e-05 | 245 | 17 | 6 | HP:0025634 | |
| HumanPheno | Supernumerary cusp | 1.04e-04 | 5 | 17 | 2 | HP:0033777 | |
| HumanPheno | Conductive hearing impairment | 1.09e-04 | 373 | 17 | 7 | HP:0000405 | |
| HumanPheno | Thick eyebrow | 1.09e-04 | 154 | 17 | 5 | HP:0000574 | |
| HumanPheno | Abnormal epididymis morphology | 1.19e-04 | 30 | 17 | 3 | HP:0009714 | |
| HumanPheno | Functional abnormality of the middle ear | 1.36e-04 | 386 | 17 | 7 | HP:0011452 | |
| HumanPheno | Elbow dislocation | 1.39e-04 | 84 | 17 | 4 | HP:0003042 | |
| HumanPheno | Autism | 1.40e-04 | 264 | 17 | 6 | HP:0000717 | |
| HumanPheno | Pancreatic aplasia | 1.56e-04 | 6 | 17 | 2 | HP:0100801 | |
| HumanPheno | Large foramen magnum | 1.56e-04 | 6 | 17 | 2 | HP:0002700 | |
| HumanPheno | Frontal upsweep of hair | 1.58e-04 | 33 | 17 | 3 | HP:0002236 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 1.58e-04 | 33 | 17 | 3 | HP:0011587 | |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 2.06e-04 | 36 | 17 | 3 | HP:0009617 | |
| HumanPheno | Deviated nasal septum | 2.18e-04 | 7 | 17 | 2 | HP:0004411 | |
| HumanPheno | Upper extremity joint dislocation | 2.34e-04 | 96 | 17 | 4 | HP:0030310 | |
| HumanPheno | Abnormality of the hairline | 2.53e-04 | 294 | 17 | 6 | HP:0009553 | |
| HumanPheno | Cellular immunodeficiency | 2.62e-04 | 39 | 17 | 3 | HP:0005374 | |
| HumanPheno | Functional abnormality of the bladder | 2.89e-04 | 590 | 17 | 8 | HP:0000009 | |
| HumanPheno | Language impairment | HNF1B RPGR STIL MAN2B1 ATXN2 CNOT1 CREBBP CCNK MEF2C EP300 BRD4 | 2.95e-04 | 1178 | 17 | 11 | HP:0002463 |
| HumanPheno | Abnormal hair whorl | 3.27e-04 | 42 | 17 | 3 | HP:0010721 | |
| HumanPheno | Radial deviation of finger | 3.46e-04 | 448 | 17 | 7 | HP:0009466 | |
| HumanPheno | Pilomatrixoma | 3.72e-04 | 9 | 17 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 3.72e-04 | 9 | 17 | 2 | HP:0002341 | |
| HumanPheno | Meningioma | 3.76e-04 | 44 | 17 | 3 | HP:0002858 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 3.86e-04 | 456 | 17 | 7 | HP:0009485 | |
| HumanPheno | Abnormality of the bladder | 4.13e-04 | 621 | 17 | 8 | HP:0000014 | |
| HumanPheno | Highly arched eyebrow | 4.28e-04 | 206 | 17 | 5 | HP:0002553 | |
| HumanPheno | Congenital abnormal hair pattern | 4.51e-04 | 327 | 17 | 6 | HP:0011361 | |
| HumanPheno | Frontal hirsutism | 4.64e-04 | 10 | 17 | 2 | HP:0011335 | |
| HumanPheno | Low posterior hairline | 4.99e-04 | 117 | 17 | 4 | HP:0002162 | |
| HumanPheno | Abnormality of the posterior hairline | 4.99e-04 | 117 | 17 | 4 | HP:0030141 | |
| HumanPheno | Abnormality of the frontal hairline | 5.22e-04 | 215 | 17 | 5 | HP:0000599 | |
| HumanPheno | Maladaptive fear-related cognitions | 5.51e-04 | 483 | 17 | 7 | HP:5200230 | |
| HumanPheno | Anxiety | 5.51e-04 | 483 | 17 | 7 | HP:0000739 | |
| HumanPheno | Spinocerebellar tract degeneration | 5.67e-04 | 11 | 17 | 2 | HP:0002503 | |
| HumanPheno | Abnormal subclavian artery morphology | 5.67e-04 | 11 | 17 | 2 | HP:0031251 | |
| HumanPheno | Self-mutilation | 5.82e-04 | 51 | 17 | 3 | HP:0000742 | |
| HumanPheno | Vesicoureteral reflux | 5.92e-04 | 221 | 17 | 5 | HP:0000076 | |
| HumanPheno | Abnormal cerebral ventricle morphology | 6.02e-04 | 1046 | 17 | 10 | HP:0002118 | |
| HumanPheno | Immunodeficiency | 6.05e-04 | 222 | 17 | 5 | HP:0002721 | |
| HumanPheno | Abnormal proximal phalanx morphology of the hand | 6.17e-04 | 52 | 17 | 3 | HP:0009834 | |
| HumanPheno | Abnormal atrioventricular valve morphology | 6.51e-04 | 350 | 17 | 6 | HP:0006705 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 6.53e-04 | 53 | 17 | 3 | HP:0009906 | |
| HumanPheno | Short thumb | 6.82e-04 | 127 | 17 | 4 | HP:0009778 | |
| HumanPheno | Dislocated radial head | 6.89e-04 | 54 | 17 | 3 | HP:0003083 | |
| HumanPheno | Cerebral white matter atrophy | 6.89e-04 | 54 | 17 | 3 | HP:0012762 | |
| HumanPheno | Autistic behavior | 7.59e-04 | 678 | 17 | 8 | HP:0000729 | |
| HumanPheno | Facial grimacing | 8.00e-04 | 13 | 17 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 8.00e-04 | 13 | 17 | 2 | HP:0010562 | |
| HumanPheno | Abnormality of the spinocerebellar tracts | 8.00e-04 | 13 | 17 | 2 | HP:0003133 | |
| HumanPheno | Abnormality of the radial head | 8.08e-04 | 57 | 17 | 3 | HP:0003995 | |
| HumanPheno | Abnormal judgment | 8.26e-04 | 516 | 17 | 7 | HP:5200401 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 8.51e-04 | 368 | 17 | 6 | HP:0031432 | |
| HumanPheno | Duplication of phalanx of hallux | 9.32e-04 | 14 | 17 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 9.32e-04 | 14 | 17 | 2 | HP:0012304 | |
| HumanPheno | Parietal foramina | 9.32e-04 | 14 | 17 | 2 | HP:0002697 | |
| HumanPheno | Pulmonic stenosis | 9.33e-04 | 138 | 17 | 4 | HP:0001642 | |
| HumanPheno | Perseverative thought | 9.68e-04 | 377 | 17 | 6 | HP:0030223 | |
| HumanPheno | Abnormal incisor morphology | 1.03e-03 | 62 | 17 | 3 | HP:0011063 | |
| HumanPheno | Abnormality of the humeroradial joint | 1.03e-03 | 62 | 17 | 3 | HP:0100744 | |
| HumanPheno | Deviation of finger | 1.05e-03 | 537 | 17 | 7 | HP:0004097 | |
| HumanPheno | Abnormality of the ureter | 1.05e-03 | 383 | 17 | 6 | HP:0000069 | |
| HumanPheno | Abnormal fear-induced behavior | 1.06e-03 | 538 | 17 | 7 | HP:0100852 | |
| HumanPheno | Abnormal scrotum morphology | 1.07e-03 | 143 | 17 | 4 | HP:0000045 | |
| HumanPheno | Duplication of phalanx of toe | 1.07e-03 | 15 | 17 | 2 | HP:0010181 | |
| HumanPheno | Social and occupational deterioration | 1.07e-03 | 15 | 17 | 2 | HP:0007086 | |
| HumanPheno | Hypoplastic ilia | 1.08e-03 | 63 | 17 | 3 | HP:0000946 | |
| HumanPheno | Disordered formal thought process | 1.10e-03 | 386 | 17 | 6 | HP:0025769 | |
| HumanPheno | Abnormality of the uterus | 1.16e-03 | 256 | 17 | 5 | HP:0000130 | |
| HumanPheno | Low anterior hairline | 1.18e-03 | 147 | 17 | 4 | HP:0000294 | |
| HumanPheno | Aplasia/Hypoplasia of the thumb | 1.27e-03 | 150 | 17 | 4 | HP:0009601 | |
| HumanPheno | Genital neoplasm | 1.27e-03 | 150 | 17 | 4 | HP:0010787 | |
| HumanPheno | Abnormal palmar dermatoglyphics | 1.35e-03 | 265 | 17 | 5 | HP:0001018 | |
| HumanPheno | Abnormality of the lower urinary tract | 1.37e-03 | 937 | 17 | 9 | HP:0010936 | |
| HumanPheno | Premature thelarche | 1.38e-03 | 17 | 17 | 2 | HP:0010314 | |
| HumanPheno | Abnormal thought pattern | 1.39e-03 | 404 | 17 | 6 | HP:5200269 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | 1.41e-03 | 564 | 17 | 7 | HP:0009484 | |
| HumanPheno | Diagnostic behavioral phenotype | 1.46e-03 | 747 | 17 | 8 | HP:0025783 | |
| HumanPheno | Intestinal malrotation | 1.51e-03 | 157 | 17 | 4 | HP:0002566 | |
| MousePheno | abnormal vasculogenesis | 5.06e-06 | 54 | 30 | 4 | MP:0001622 | |
| MousePheno | embryonic growth retardation | 2.08e-05 | 763 | 30 | 9 | MP:0003984 | |
| MousePheno | prenatal growth retardation | 5.80e-05 | 869 | 30 | 9 | MP:0010865 | |
| MousePheno | failure of heart looping | 1.04e-04 | 43 | 30 | 3 | MP:0004251 | |
| MousePheno | incomplete somite formation | 1.11e-04 | 44 | 30 | 3 | MP:0001689 | |
| MousePheno | abnormal heart development | 1.18e-04 | 372 | 30 | 6 | MP:0000267 | |
| MousePheno | absent organized vascular network | 1.24e-04 | 8 | 30 | 2 | MP:0000263 | |
| MousePheno | abnormal vertebrae morphology | 1.24e-04 | 546 | 30 | 7 | MP:0000137 | |
| MousePheno | abnormal vitelline vasculature morphology | 1.30e-04 | 235 | 30 | 5 | MP:0003229 | |
| MousePheno | abnormal blood vessel morphology | PAXIP1 RNF38 CHD7 RPGR MAN2B1 CREBBP MEF2C EP300 BRD4 HPS1 SMAD5 | 1.39e-04 | 1472 | 30 | 11 | MP:0001614 |
| MousePheno | abnormal digestive system morphology | 1.60e-04 | 1233 | 30 | 10 | MP:0000462 | |
| MousePheno | abnormal artery development | 1.77e-04 | 133 | 30 | 4 | MP:0003410 | |
| MousePheno | short premaxilla | 3.42e-04 | 13 | 30 | 2 | MP:0000091 | |
| MousePheno | incomplete embryo turning | 3.56e-04 | 65 | 30 | 3 | MP:0001701 | |
| MousePheno | abnormal placing response | 3.99e-04 | 14 | 30 | 2 | MP:0001526 | |
| MousePheno | ventricle myocardium hypoplasia | 4.62e-04 | 71 | 30 | 3 | MP:0010502 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 5.67e-04 | 700 | 30 | 7 | MP:0011098 | |
| Domain | - | 3.82e-06 | 2 | 37 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 3.82e-06 | 2 | 37 | 2 | PF02135 | |
| Domain | ZF_TAZ | 3.82e-06 | 2 | 37 | 2 | PS50134 | |
| Domain | Nuc_rcpt_coact_CREBbp | 3.82e-06 | 2 | 37 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 3.82e-06 | 2 | 37 | 2 | PF08214 | |
| Domain | KIX | 3.82e-06 | 2 | 37 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 3.82e-06 | 2 | 37 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 3.82e-06 | 2 | 37 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 3.82e-06 | 2 | 37 | 2 | IPR013178 | |
| Domain | DUF902 | 3.82e-06 | 2 | 37 | 2 | PF06001 | |
| Domain | - | 3.82e-06 | 2 | 37 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 3.82e-06 | 2 | 37 | 2 | IPR010303 | |
| Domain | KAT11 | 3.82e-06 | 2 | 37 | 2 | SM01250 | |
| Domain | - | 3.82e-06 | 2 | 37 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 3.82e-06 | 2 | 37 | 2 | IPR000197 | |
| Domain | KIX_dom | 3.82e-06 | 2 | 37 | 2 | IPR003101 | |
| Domain | Creb_binding | 3.82e-06 | 2 | 37 | 2 | PF09030 | |
| Domain | KIX | 3.82e-06 | 2 | 37 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 3.82e-06 | 2 | 37 | 2 | PS51727 | |
| Domain | Bromodomain_CS | 1.80e-05 | 26 | 37 | 3 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 5.31e-05 | 37 | 37 | 3 | PS00633 | |
| Domain | Nuc_rcpt_coact | 5.70e-05 | 6 | 37 | 2 | IPR009110 | |
| Domain | Bromodomain | 5.76e-05 | 38 | 37 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 7.24e-05 | 41 | 37 | 3 | PS50014 | |
| Domain | BROMO | 7.79e-05 | 42 | 37 | 3 | SM00297 | |
| Domain | Bromodomain | 7.79e-05 | 42 | 37 | 3 | IPR001487 | |
| Domain | - | 7.79e-05 | 42 | 37 | 3 | 1.20.920.10 | |
| Domain | HMG_BOX_1 | 1.70e-04 | 10 | 37 | 2 | PS00353 | |
| Domain | ZF_ZZ_2 | 5.73e-04 | 18 | 37 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 5.73e-04 | 18 | 37 | 2 | PS01357 | |
| Domain | ZZ | 5.73e-04 | 18 | 37 | 2 | PF00569 | |
| Domain | Znf_ZZ | 6.39e-04 | 19 | 37 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 6.39e-04 | 19 | 37 | 2 | SM00291 | |
| Domain | WW | 3.90e-03 | 47 | 37 | 2 | PF00397 | |
| Domain | WW | 4.07e-03 | 48 | 37 | 2 | SM00456 | |
| Domain | SANT | 4.41e-03 | 50 | 37 | 2 | SM00717 | |
| Domain | WW_DOMAIN_2 | 4.58e-03 | 51 | 37 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 4.58e-03 | 51 | 37 | 2 | PS01159 | |
| Domain | WW_dom | 4.76e-03 | 52 | 37 | 2 | IPR001202 | |
| Domain | zf-RING_2 | 4.76e-03 | 52 | 37 | 2 | PF13639 | |
| Domain | SANT/Myb | 4.76e-03 | 52 | 37 | 2 | IPR001005 | |
| Domain | HMG_box | 4.94e-03 | 53 | 37 | 2 | PF00505 | |
| Domain | HMG_BOX_2 | 5.12e-03 | 54 | 37 | 2 | PS50118 | |
| Domain | HMG | 5.12e-03 | 54 | 37 | 2 | SM00398 | |
| Domain | - | 5.31e-03 | 55 | 37 | 2 | 1.10.30.10 | |
| Domain | HMG_box_dom | 7.34e-03 | 65 | 37 | 2 | IPR009071 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 4.77e-07 | 143 | 30 | 6 | M39591 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 4.78e-06 | 16 | 30 | 3 | M27121 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 1.61e-05 | 153 | 30 | 5 | M39546 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 2.19e-05 | 26 | 30 | 3 | M2499 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 2.60e-05 | 82 | 30 | 4 | M2 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 3.13e-05 | 86 | 30 | 4 | M2642 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 4.36e-05 | 5 | 30 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 4.36e-05 | 5 | 30 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 4.36e-05 | 5 | 30 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 4.36e-05 | 5 | 30 | 2 | M48023 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 6.53e-05 | 6 | 30 | 2 | M22062 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 9.13e-05 | 7 | 30 | 2 | MM1573 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 9.44e-05 | 42 | 30 | 3 | M17541 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.22e-04 | 8 | 30 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.22e-04 | 8 | 30 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.22e-04 | 8 | 30 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.22e-04 | 8 | 30 | 2 | M46443 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.50e-04 | 49 | 30 | 3 | M41832 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.56e-04 | 9 | 30 | 2 | M47451 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.90e-04 | 53 | 30 | 3 | MM15880 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.95e-04 | 10 | 30 | 2 | M27945 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 2.12e-04 | 55 | 30 | 3 | M39351 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.38e-04 | 11 | 30 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 2.38e-04 | 11 | 30 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 2.38e-04 | 11 | 30 | 2 | M26924 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 2.61e-04 | 59 | 30 | 3 | M39886 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.85e-04 | 12 | 30 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.85e-04 | 12 | 30 | 2 | M27765 | |
| Pathway | PID_RB_1PATHWAY | 3.48e-04 | 65 | 30 | 3 | M279 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.56e-04 | 161 | 30 | 4 | M27871 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 3.64e-04 | 66 | 30 | 3 | M101 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.92e-04 | 14 | 30 | 2 | M27808 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 4.32e-04 | 70 | 30 | 3 | M938 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 4.52e-04 | 15 | 30 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 4.52e-04 | 15 | 30 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 4.52e-04 | 15 | 30 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 4.52e-04 | 15 | 30 | 2 | M953 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 5.16e-04 | 16 | 30 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 5.16e-04 | 16 | 30 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 5.16e-04 | 16 | 30 | 2 | M8516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 5.16e-04 | 16 | 30 | 2 | M27940 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 5.84e-04 | 17 | 30 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 5.84e-04 | 17 | 30 | 2 | M48025 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 6.56e-04 | 18 | 30 | 2 | M26942 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 7.32e-04 | 19 | 30 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 7.32e-04 | 19 | 30 | 2 | M46442 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 7.38e-04 | 84 | 30 | 3 | M1008 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.12e-04 | 20 | 30 | 2 | M27881 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 8.97e-04 | 21 | 30 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 8.97e-04 | 21 | 30 | 2 | M27485 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 9.85e-04 | 22 | 30 | 2 | MM1443 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 9.85e-04 | 22 | 30 | 2 | MM1370 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.02e-03 | 94 | 30 | 3 | M1041 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.08e-03 | 23 | 30 | 2 | M2821 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.09e-03 | 96 | 30 | 3 | M27784 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 1.15e-03 | 98 | 30 | 3 | M48247 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.17e-03 | 24 | 30 | 2 | M13404 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.26e-03 | 101 | 30 | 3 | MM15829 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.27e-03 | 25 | 30 | 2 | M27880 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 1.38e-03 | 26 | 30 | 2 | M32 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.60e-03 | 28 | 30 | 2 | M27254 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.61e-03 | 110 | 30 | 3 | M48259 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.84e-03 | 30 | 30 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.84e-03 | 30 | 30 | 2 | M936 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 1.96e-03 | 31 | 30 | 2 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 1.96e-03 | 31 | 30 | 2 | MM14789 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.97e-03 | 118 | 30 | 3 | M27316 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.97e-03 | 118 | 30 | 3 | MM15588 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 2.07e-03 | 120 | 30 | 3 | M48233 | |
| Pathway | WP_PRION_DISEASE_PATHWAY | 2.09e-03 | 32 | 30 | 2 | M39636 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 2.09e-03 | 32 | 30 | 2 | M39521 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 2.16e-03 | 122 | 30 | 3 | M29689 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 2.35e-03 | 34 | 30 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 2.35e-03 | 34 | 30 | 2 | M44 | |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 2.48e-03 | 128 | 30 | 3 | M48019 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 2.49e-03 | 35 | 30 | 2 | M48246 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 2.64e-03 | 36 | 30 | 2 | M633 | |
| Pathway | BIOCARTA_ALK_PATHWAY | 2.78e-03 | 37 | 30 | 2 | M17400 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.93e-03 | 38 | 30 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.93e-03 | 38 | 30 | 2 | M27255 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 3.01e-03 | 137 | 30 | 3 | M145 | |
| Pathway | PID_FOXM1_PATHWAY | 3.25e-03 | 40 | 30 | 2 | M176 | |
| Pathway | PID_IFNG_PATHWAY | 3.25e-03 | 40 | 30 | 2 | M161 | |
| Pathway | WP_ECTODERM_DIFFERENTIATION | 3.33e-03 | 142 | 30 | 3 | M39575 | |
| Pathway | WP_MALE_INFERTILITY | 3.53e-03 | 145 | 30 | 3 | M39856 | |
| Pathway | PID_BMP_PATHWAY | 3.58e-03 | 42 | 30 | 2 | M181 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 3.60e-03 | 301 | 30 | 4 | MM15983 | |
| Pathway | PID_HNF3A_PATHWAY | 3.92e-03 | 44 | 30 | 2 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.92e-03 | 44 | 30 | 2 | M27295 | |
| Pathway | PID_HNF3B_PATHWAY | 4.09e-03 | 45 | 30 | 2 | M106 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.46e-03 | 47 | 30 | 2 | M7946 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 4.57e-03 | 159 | 30 | 3 | M39373 | |
| Pathway | WP_ENERGY_METABOLISM | 4.65e-03 | 48 | 30 | 2 | M39590 | |
| Pathway | PID_HES_HEY_PATHWAY | 4.65e-03 | 48 | 30 | 2 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.65e-03 | 48 | 30 | 2 | M611 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 4.84e-03 | 49 | 30 | 2 | MM1442 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 4.84e-03 | 49 | 30 | 2 | M27614 | |
| Pathway | PID_FOXO_PATHWAY | 4.84e-03 | 49 | 30 | 2 | M136 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.84e-03 | 49 | 30 | 2 | M618 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 5.23e-03 | 51 | 30 | 2 | M665 | |
| Pubmed | 3.93e-11 | 23 | 38 | 5 | 9225980 | ||
| Pubmed | PAXIP1 TRERF1 MED15 HNF1B SCAF11 CHD7 ZFHX4 ATXN2 CNOT1 CREBBP MEF2C EP300 EMSY SMAD5 | 1.41e-10 | 1429 | 38 | 14 | 35140242 | |
| Pubmed | 4.48e-10 | 268 | 38 | 8 | 33640491 | ||
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 27903646 | ||
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 11349124 | ||
| Pubmed | PAXIP1 TRERF1 MED15 ZNF384 CHD7 ATXN2 CNOT1 CREBBP CCNK EP300 EMSY BRD4 | 1.23e-09 | 1103 | 38 | 12 | 34189442 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.73e-09 | 351 | 38 | 8 | 38297188 | |
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 9001254 | ||
| Pubmed | 1.20e-08 | 5 | 38 | 3 | 9990060 | ||
| Pubmed | Hgs physically interacts with Smad5 and attenuates BMP signaling. | 1.20e-08 | 5 | 38 | 3 | 16516194 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.27e-07 | 398 | 38 | 7 | 35016035 | |
| Pubmed | 8.32e-07 | 66 | 38 | 4 | 23275444 | ||
| Pubmed | Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. | 1.15e-06 | 19 | 38 | 3 | 27626385 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.16e-06 | 2 | 38 | 2 | 34845315 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 19729597 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 15860545 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 1.16e-06 | 2 | 38 | 2 | 24551300 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 29531323 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 33911074 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 9018065 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 24648406 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 30135524 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 1.16e-06 | 2 | 38 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 1.16e-06 | 2 | 38 | 2 | 29217654 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 20717166 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 1.16e-06 | 2 | 38 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 1.16e-06 | 2 | 38 | 2 | 29170789 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 25893291 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 11559821 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 1.16e-06 | 2 | 38 | 2 | 12646247 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 32576962 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 19822209 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 24522976 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 1.16e-06 | 2 | 38 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 1.16e-06 | 2 | 38 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 1.16e-06 | 2 | 38 | 2 | 34813504 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 1.16e-06 | 2 | 38 | 2 | 12696060 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 1.16e-06 | 2 | 38 | 2 | 36109165 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 24639469 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 37816914 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12697058 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12242694 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 1.16e-06 | 2 | 38 | 2 | 11438528 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 10918613 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 31182547 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 35502657 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 30635043 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 1.16e-06 | 2 | 38 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 1.16e-06 | 2 | 38 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 1.16e-06 | 2 | 38 | 2 | 27881443 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 19272189 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 1.16e-06 | 2 | 38 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 1.16e-06 | 2 | 38 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 1.16e-06 | 2 | 38 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 1.16e-06 | 2 | 38 | 2 | 32690000 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 9733868 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 30953353 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 21803292 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 9811832 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 24089570 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 1.16e-06 | 2 | 38 | 2 | 33063428 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 34506759 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 22177454 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 1.16e-06 | 2 | 38 | 2 | 39266679 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 22303793 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 1.16e-06 | 2 | 38 | 2 | 34019788 | |
| Pubmed | 1.39e-06 | 75 | 38 | 4 | 25593309 | ||
| Pubmed | 1.94e-06 | 549 | 38 | 7 | 38280479 | ||
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 2.10e-06 | 23 | 38 | 3 | 10235267 | |
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 3.48e-06 | 3 | 38 | 2 | 14716005 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18070920 | ||
| Pubmed | The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. | 3.48e-06 | 3 | 38 | 2 | 21967847 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 28378055 | ||
| Pubmed | CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. | 3.48e-06 | 3 | 38 | 2 | 19252086 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 12748286 | ||
| Pubmed | Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice. | 3.48e-06 | 3 | 38 | 2 | 32544088 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 10075656 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 24340053 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19273602 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15649887 | ||
| Pubmed | Expression patterns of histone acetyltransferases p300 and CBP during murine tooth development. | 3.48e-06 | 3 | 38 | 2 | 22179676 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 17410209 | ||
| Pubmed | DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. | 3.48e-06 | 3 | 38 | 2 | 26951377 | |
| Pubmed | CBP/p300 and SIRT1 are involved in transcriptional regulation of S-phase specific histone genes. | 3.48e-06 | 3 | 38 | 2 | 21789216 | |
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 3.48e-06 | 3 | 38 | 2 | 12050117 | |
| Pubmed | Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. | 3.48e-06 | 3 | 38 | 2 | 16237459 | |
| Pubmed | A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. | 3.48e-06 | 3 | 38 | 2 | 12384703 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 10350644 | ||
| Interaction | SOX7 interactions | 7.92e-09 | 82 | 37 | 6 | int:SOX7 | |
| Interaction | CRX interactions | 1.61e-08 | 254 | 37 | 8 | int:CRX | |
| Interaction | SOX9 interactions | 2.19e-08 | 97 | 37 | 6 | int:SOX9 | |
| Interaction | EGR2 interactions | 2.33e-08 | 171 | 37 | 7 | int:EGR2 | |
| Interaction | PAX8 interactions | 4.93e-08 | 111 | 37 | 6 | int:PAX8 | |
| Interaction | TBR1 interactions | 5.48e-08 | 113 | 37 | 6 | int:TBR1 | |
| Interaction | PAX7 interactions | 9.55e-08 | 124 | 37 | 6 | int:PAX7 | |
| Interaction | RUNX2 interactions | 1.05e-07 | 126 | 37 | 6 | int:RUNX2 | |
| Interaction | ERG interactions | 1.44e-07 | 223 | 37 | 7 | int:ERG | |
| Interaction | MED23 interactions | 4.73e-07 | 266 | 37 | 7 | int:MED23 | |
| Interaction | XRCC6 interactions | PAXIP1 SMURF1 HNF1B SCAF11 CHD7 SGO1 CREBBP CCNK EP300 EMSY BRD4 | 5.28e-07 | 928 | 37 | 11 | int:XRCC6 |
| Interaction | TEAD1 interactions | 7.56e-07 | 176 | 37 | 6 | int:TEAD1 | |
| Interaction | RBBP5 interactions | 7.89e-07 | 287 | 37 | 7 | int:RBBP5 | |
| Interaction | SP7 interactions | 1.16e-06 | 304 | 37 | 7 | int:SP7 | |
| Interaction | HNF1B interactions | 1.18e-06 | 190 | 37 | 6 | int:HNF1B | |
| Interaction | CEBPA interactions | PAXIP1 TRERF1 MED15 ZNF384 CHD7 ATXN2 CNOT1 CREBBP CCNK EP300 EMSY BRD4 | 1.28e-06 | 1245 | 37 | 12 | int:CEBPA |
| Interaction | FEV interactions | 1.74e-06 | 203 | 37 | 6 | int:FEV | |
| Interaction | RUNX1 interactions | 1.77e-06 | 324 | 37 | 7 | int:RUNX1 | |
| Interaction | TBXT interactions | 2.18e-06 | 116 | 37 | 5 | int:TBXT | |
| Interaction | KLF2 interactions | 2.55e-06 | 15 | 37 | 3 | int:KLF2 | |
| Interaction | YAP1 interactions | TRERF1 MED15 SMURF1 RNF38 HNF1B CNOT1 CREBBP CCNK EP300 BRD4 SMAD5 | 2.68e-06 | 1095 | 37 | 11 | int:YAP1 |
| Interaction | PAX6 interactions | 3.96e-06 | 366 | 37 | 7 | int:PAX6 | |
| Interaction | MYB interactions | 4.27e-06 | 133 | 37 | 5 | int:MYB | |
| Interaction | RUNX3 interactions | 4.66e-06 | 61 | 37 | 4 | int:RUNX3 | |
| Interaction | TLE3 interactions | 4.73e-06 | 376 | 37 | 7 | int:TLE3 | |
| Interaction | SMAD2 interactions | 5.52e-06 | 385 | 37 | 7 | int:SMAD2 | |
| Interaction | H3-3A interactions | 6.29e-06 | 749 | 37 | 9 | int:H3-3A | |
| Interaction | GUSBP5 interactions | 1.06e-05 | 75 | 37 | 4 | int:GUSBP5 | |
| Interaction | HNF1A interactions | 1.38e-05 | 80 | 37 | 4 | int:HNF1A | |
| Interaction | EPAS1 interactions | 1.54e-05 | 173 | 37 | 5 | int:EPAS1 | |
| Interaction | TLX1 interactions | 1.62e-05 | 175 | 37 | 5 | int:TLX1 | |
| Interaction | PAX2 interactions | 1.75e-05 | 85 | 37 | 4 | int:PAX2 | |
| Interaction | GSC interactions | 1.92e-05 | 87 | 37 | 4 | int:GSC | |
| Interaction | GATA3 interactions | 2.23e-05 | 187 | 37 | 5 | int:GATA3 | |
| Interaction | NFIA interactions | 2.29e-05 | 188 | 37 | 5 | int:NFIA | |
| Interaction | NANOG interactions | 2.34e-05 | 481 | 37 | 7 | int:NANOG | |
| Interaction | SOX10 interactions | 2.39e-05 | 92 | 37 | 4 | int:SOX10 | |
| Interaction | FOXI1 interactions | 2.39e-05 | 92 | 37 | 4 | int:FOXI1 | |
| Interaction | TRERF1 interactions | 2.99e-05 | 33 | 37 | 3 | int:TRERF1 | |
| Interaction | GATA2 interactions | 3.01e-05 | 199 | 37 | 5 | int:GATA2 | |
| Interaction | CNOT3 interactions | 3.63e-05 | 207 | 37 | 5 | int:CNOT3 | |
| Interaction | SND1 interactions | 3.70e-05 | 347 | 37 | 6 | int:SND1 | |
| Interaction | ING1 interactions | 3.73e-05 | 103 | 37 | 4 | int:ING1 | |
| Interaction | NFIC interactions | 3.89e-05 | 210 | 37 | 5 | int:NFIC | |
| Interaction | EN1 interactions | 4.83e-05 | 110 | 37 | 4 | int:EN1 | |
| Interaction | NCOA3 interactions | 5.29e-05 | 224 | 37 | 5 | int:NCOA3 | |
| Interaction | PROX1 interactions | 5.79e-05 | 41 | 37 | 3 | int:PROX1 | |
| Interaction | AR interactions | 5.84e-05 | 992 | 37 | 9 | int:AR | |
| Interaction | MED28 interactions | 5.94e-05 | 116 | 37 | 4 | int:MED28 | |
| Interaction | GPKOW interactions | 6.35e-05 | 118 | 37 | 4 | int:GPKOW | |
| Interaction | JUNB interactions | 6.35e-05 | 118 | 37 | 4 | int:JUNB | |
| Interaction | UBTF interactions | 6.51e-05 | 234 | 37 | 5 | int:UBTF | |
| Interaction | ETS1 interactions | 7.01e-05 | 121 | 37 | 4 | int:ETS1 | |
| Interaction | ASCL1 interactions | 7.67e-05 | 45 | 37 | 3 | int:ASCL1 | |
| Interaction | FHL2 interactions | 7.69e-05 | 396 | 37 | 6 | int:FHL2 | |
| Interaction | SMAD1 interactions | 7.78e-05 | 243 | 37 | 5 | int:SMAD1 | |
| Interaction | EYA4 interactions | 7.78e-05 | 243 | 37 | 5 | int:EYA4 | |
| Interaction | CDC16 interactions | 8.24e-05 | 246 | 37 | 5 | int:CDC16 | |
| Interaction | ATXN1 interactions | 8.35e-05 | 1039 | 37 | 9 | int:ATXN1 | |
| Interaction | MARF1 interactions | 8.72e-05 | 128 | 37 | 4 | int:MARF1 | |
| Interaction | ASF1A interactions | 8.73e-05 | 249 | 37 | 5 | int:ASF1A | |
| Interaction | PAX9 interactions | 9.26e-05 | 130 | 37 | 4 | int:PAX9 | |
| Interaction | MDC1 interactions | 9.82e-05 | 414 | 37 | 6 | int:MDC1 | |
| Interaction | WEE1 interactions | 1.01e-04 | 133 | 37 | 4 | int:WEE1 | |
| Interaction | OXER1 interactions | 1.05e-04 | 50 | 37 | 3 | int:OXER1 | |
| Interaction | WWTR1 interactions | 1.09e-04 | 422 | 37 | 6 | int:WWTR1 | |
| Interaction | EID1 interactions | 1.12e-04 | 51 | 37 | 3 | int:EID1 | |
| Interaction | NUP35 interactions | 1.12e-04 | 424 | 37 | 6 | int:NUP35 | |
| Interaction | ANAPC5 interactions | 1.17e-04 | 138 | 37 | 4 | int:ANAPC5 | |
| Interaction | ASH2L interactions | 1.17e-04 | 265 | 37 | 5 | int:ASH2L | |
| Interaction | HOXB3 interactions | 1.17e-04 | 9 | 37 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 1.17e-04 | 9 | 37 | 2 | int:ARGFX | |
| Interaction | GTF2B interactions | 1.27e-04 | 141 | 37 | 4 | int:GTF2B | |
| Interaction | NCOA2 interactions | 1.27e-04 | 141 | 37 | 4 | int:NCOA2 | |
| Interaction | NFIB interactions | 1.30e-04 | 142 | 37 | 4 | int:NFIB | |
| Interaction | HDAC1 interactions | 1.37e-04 | 1108 | 37 | 9 | int:HDAC1 | |
| Interaction | HNF4A interactions | 1.39e-04 | 275 | 37 | 5 | int:HNF4A | |
| Interaction | NCOA6 interactions | 1.41e-04 | 145 | 37 | 4 | int:NCOA6 | |
| Interaction | ELF5 interactions | 1.49e-04 | 147 | 37 | 4 | int:ELF5 | |
| Interaction | POU6F2 interactions | 1.53e-04 | 148 | 37 | 4 | int:POU6F2 | |
| Interaction | RTF1 interactions | 1.61e-04 | 150 | 37 | 4 | int:RTF1 | |
| Interaction | SREBF1 interactions | 1.61e-04 | 150 | 37 | 4 | int:SREBF1 | |
| Interaction | YY1 interactions | 1.63e-04 | 454 | 37 | 6 | int:YY1 | |
| Interaction | SOX2 interactions | PAXIP1 TRERF1 ZNF384 HNF1B CHD7 ZFHX4 CNOT1 CCNK MEF2C EP300 | 1.77e-04 | 1422 | 37 | 10 | int:SOX2 |
| Interaction | TLX3 interactions | 1.81e-04 | 291 | 37 | 5 | int:TLX3 | |
| Interaction | SOX6 interactions | 1.92e-04 | 157 | 37 | 4 | int:SOX6 | |
| Interaction | HOXA10 interactions | 2.00e-04 | 62 | 37 | 3 | int:HOXA10 | |
| Interaction | EDC3 interactions | 2.11e-04 | 161 | 37 | 4 | int:EDC3 | |
| Interaction | KDM6A interactions | 2.16e-04 | 162 | 37 | 4 | int:KDM6A | |
| Interaction | ANAPC7 interactions | 2.16e-04 | 162 | 37 | 4 | int:ANAPC7 | |
| Interaction | SOX5 interactions | 2.16e-04 | 162 | 37 | 4 | int:SOX5 | |
| Interaction | ATF1 interactions | 2.30e-04 | 65 | 37 | 3 | int:ATF1 | |
| Interaction | PPARG interactions | 2.32e-04 | 307 | 37 | 5 | int:PPARG | |
| Interaction | H2BC21 interactions | 2.37e-04 | 696 | 37 | 7 | int:H2BC21 | |
| Interaction | DCP1A interactions | 2.37e-04 | 166 | 37 | 4 | int:DCP1A | |
| Interaction | KDM1A interactions | 2.53e-04 | 941 | 37 | 8 | int:KDM1A | |
| Interaction | TP73 interactions | 2.54e-04 | 169 | 37 | 4 | int:TP73 | |
| Interaction | RXRA interactions | 2.54e-04 | 169 | 37 | 4 | int:RXRA | |
| Interaction | KMT2D interactions | 2.54e-04 | 169 | 37 | 4 | int:KMT2D | |
| Interaction | SETD1A interactions | 2.60e-04 | 170 | 37 | 4 | int:SETD1A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q12 | 2.66e-03 | 92 | 38 | 2 | chr8q12 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.72e-10 | 25 | 25 | 5 | 775 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.46e-04 | 17 | 25 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.77e-04 | 18 | 25 | 2 | 91 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.42e-03 | 53 | 25 | 2 | 532 | |
| GeneFamily | PDZ domain containing | 1.86e-02 | 152 | 25 | 2 | 1220 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | PAXIP1 SCAF11 CHD7 RPGR STIL TOX SGO1 CCNK ZGRF1 EMSY BRD4 SMAD5 TOX3 | 2.55e-07 | 1459 | 35 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | PAXIP1 SCAF11 RPGR STIL TOX SGO1 CCNK ZGRF1 EMSY BRD4 SMAD5 TOX3 | 4.11e-07 | 1257 | 35 | 12 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.91e-06 | 532 | 35 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 2.32e-05 | 1252 | 35 | 10 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 4.05e-05 | 1060 | 35 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.19e-05 | 44 | 35 | 3 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 1.37e-04 | 1241 | 35 | 9 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | 1.60e-04 | 985 | 35 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | 2.88e-04 | 1370 | 35 | 9 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 3.64e-04 | 1414 | 35 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 1.28e-05 | 169 | 38 | 4 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 184 | 38 | 4 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.87e-05 | 186 | 38 | 4 | 55b239834b96b1f7787ec77a7d19796d617bbbf0 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-05 | 191 | 38 | 4 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.12e-05 | 192 | 38 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.12e-05 | 192 | 38 | 4 | 69758a256386a6ed3a6e2c94c55d59baa34892d7 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.16e-05 | 193 | 38 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-05 | 194 | 38 | 4 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-05 | 194 | 38 | 4 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 196 | 38 | 4 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 136 | 38 | 3 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | Control-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 3.28e-04 | 158 | 38 | 3 | ec425ec7b8e3c527b4bbe57908d84528b9747796 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-04 | 163 | 38 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-04 | 165 | 38 | 3 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-04 | 165 | 38 | 3 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 165 | 38 | 3 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-04 | 167 | 38 | 3 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | CV-Mild-6|CV / Virus stimulation, Condition and Cluster | 3.85e-04 | 167 | 38 | 3 | cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.99e-04 | 169 | 38 | 3 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.99e-04 | 169 | 38 | 3 | a4204bdd75837f5fee9aaac459cb4c19ee2a7bf4 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-04 | 169 | 38 | 3 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 170 | 38 | 3 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-04 | 171 | 38 | 3 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-04 | 171 | 38 | 3 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-04 | 172 | 38 | 3 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-04 | 172 | 38 | 3 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 4.27e-04 | 173 | 38 | 3 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-04 | 173 | 38 | 3 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 4.27e-04 | 173 | 38 | 3 | 62e0c18cfed9645e34a9d7029c94a8554f773714 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-04 | 173 | 38 | 3 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-04 | 174 | 38 | 3 | 66555c610251ea04f968c258e312d720c18e7cde | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 174 | 38 | 3 | 0cf40ce9d9ad926c4909665aaa224694b5d970cb | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-04 | 174 | 38 | 3 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-04 | 174 | 38 | 3 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | Dendritic_Cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.41e-04 | 175 | 38 | 3 | 584290a51f9975782a5ac8c6ad67c778d8323f8c | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 4.41e-04 | 175 | 38 | 3 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-04 | 175 | 38 | 3 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 175 | 38 | 3 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-04 | 175 | 38 | 3 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-04 | 176 | 38 | 3 | 8813c01ea080f373fe3970c5e1ba4c2dca0f7f02 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-04 | 176 | 38 | 3 | 9e719e6323597ecfc758c957256872cd4ae24d4d | |
| ToppCell | BAL-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 4.56e-04 | 177 | 38 | 3 | 939487a05311b66edfc3f44a7955fbf25266d6bf | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 4.56e-04 | 177 | 38 | 3 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-04 | 177 | 38 | 3 | ba701d3c90722d8bff70d0fa651899305cdad257 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 178 | 38 | 3 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 178 | 38 | 3 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.64e-04 | 178 | 38 | 3 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-04 | 179 | 38 | 3 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.72e-04 | 179 | 38 | 3 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.72e-04 | 179 | 38 | 3 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-04 | 179 | 38 | 3 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-04 | 180 | 38 | 3 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-04 | 180 | 38 | 3 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-04 | 180 | 38 | 3 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 180 | 38 | 3 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 180 | 38 | 3 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 180 | 38 | 3 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 180 | 38 | 3 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | control-Lymphoid-B_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.87e-04 | 181 | 38 | 3 | e414303bb90e5fe7b667c2acf9a50f8694b90e54 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 182 | 38 | 3 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 182 | 38 | 3 | fe46819c153a81911864473badc794f243705f98 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 182 | 38 | 3 | 3948422707d6d5e021bcd7158e2eb69143613f62 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.03e-04 | 183 | 38 | 3 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.11e-04 | 184 | 38 | 3 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.11e-04 | 184 | 38 | 3 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 5.11e-04 | 184 | 38 | 3 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 5.11e-04 | 184 | 38 | 3 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B-B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.11e-04 | 184 | 38 | 3 | efcd643324ccd212350dc6a27f40efbb666d557b | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.11e-04 | 184 | 38 | 3 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 5.11e-04 | 184 | 38 | 3 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 5.11e-04 | 184 | 38 | 3 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-04 | 184 | 38 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.11e-04 | 184 | 38 | 3 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.19e-04 | 185 | 38 | 3 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-04 | 185 | 38 | 3 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-04 | 185 | 38 | 3 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.27e-04 | 186 | 38 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.36e-04 | 187 | 38 | 3 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-04 | 187 | 38 | 3 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 187 | 38 | 3 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 187 | 38 | 3 | 4d12c70c8ed922fbc8f7b139145611203735cab4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 187 | 38 | 3 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-04 | 187 | 38 | 3 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 187 | 38 | 3 | e851ee46a6b4068a7bd7602ee183c0ace50ee4dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 187 | 38 | 3 | e46b49b4053d2d0f3e1d2bcdc380f7f8733cbe07 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 187 | 38 | 3 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.44e-04 | 188 | 38 | 3 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-04 | 188 | 38 | 3 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-04 | 188 | 38 | 3 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.44e-04 | 188 | 38 | 3 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-04 | 188 | 38 | 3 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.52e-04 | 189 | 38 | 3 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 189 | 38 | 3 | fcc3713e8200d51074f709f3360fb36efb0a639f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-04 | 189 | 38 | 3 | a9864873b19ab3e60acf11f288fa7275badc2e42 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-04 | 190 | 38 | 3 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-04 | 190 | 38 | 3 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.61e-04 | 190 | 38 | 3 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 191 | 38 | 3 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 5.69e-04 | 191 | 38 | 3 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.33e-05 | 195 | 36 | 5 | 3191_DN | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.40e-05 | 197 | 36 | 5 | 2300_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.43e-05 | 198 | 36 | 5 | 7279_UP | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.43e-05 | 198 | 36 | 5 | 4782_UP | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 2.42e-05 | 5 | 36 | 2 | ctd:C575894 | |
| Drug | 1-chlorobutane | 8.69e-05 | 9 | 36 | 2 | CID000008005 | |
| Drug | 2,4,5-trichlorophenol | 9.50e-05 | 56 | 36 | 3 | CID000007271 | |
| Drug | Phenylephrine | 1.28e-04 | 505 | 36 | 6 | ctd:D010656 | |
| Drug | daunorubicin HCl; Up 200; 1uM; MCF7; HT_HG-U133A | 1.95e-04 | 183 | 36 | 4 | 7507_UP | |
| Drug | N,N-diethyl-1-phenylcyclohexylamine | 2.19e-04 | 14 | 36 | 2 | CID000604690 | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 2.25e-04 | 190 | 36 | 4 | 6318_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.29e-04 | 191 | 36 | 4 | 3823_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.34e-04 | 192 | 36 | 4 | 6054_DN | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; PC3; HT_HG-U133A | 2.38e-04 | 193 | 36 | 4 | 4067_DN | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; PC3; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 6729_DN | |
| Drug | Betazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 1812_UP | |
| Drug | Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 7446_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 4653_DN | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 6561_UP | |
| Drug | 5252917; Down 200; 14uM; MCF7; HT_HG-U133A_EA | 2.48e-04 | 195 | 36 | 4 | 828_DN | |
| Drug | 5252917; Down 200; 14uM; MCF7; HT_HG-U133A_EA | 2.48e-04 | 195 | 36 | 4 | 944_DN | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A | 2.48e-04 | 195 | 36 | 4 | 1886_DN | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 4614_DN | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.53e-04 | 196 | 36 | 4 | 848_DN | |
| Drug | Bisoprolol fumarate; Down 200; 9uM; PC3; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 6748_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 5205_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 2876_DN | |
| Drug | Y-27632; Down 200; 3uM; MCF7; HT_HG-U133A_EA | 2.53e-04 | 196 | 36 | 4 | 832_DN | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 6964_UP | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 4622_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 3425_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 7259_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 3544_DN | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 1801_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; PC3; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 7278_UP | |
| Drug | Trapidil [15421-84-8]; Up 200; 19.4uM; HL60; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 3136_UP | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; PC3; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 7291_UP | |
| Drug | Altretamine [654-05-6]; Down 200; 19uM; PC3; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 4627_DN | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; PC3; HG-U133A | 2.63e-04 | 198 | 36 | 4 | 1910_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 3413_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 2128_UP | |
| Drug | Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 3551_DN | |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 6264_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; HL60; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 2449_UP | |
| Drug | Practolol [6673-35-4]; Down 200; 15uM; PC3; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 4603_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; PC3; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 4284_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 6941_UP | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; MCF7; HT_HG-U133A | 2.73e-04 | 200 | 36 | 4 | 5679_UP | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.73e-04 | 200 | 36 | 4 | 1476_DN | |
| Drug | lactofen | 2.85e-04 | 81 | 36 | 3 | CID000062276 | |
| Disease | Menke-Hennekam syndrome | 1.45e-06 | 2 | 36 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 1.45e-06 | 2 | 36 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 1.45e-06 | 2 | 36 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.45e-06 | 2 | 36 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.45e-06 | 2 | 36 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 1.45e-06 | 2 | 36 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 1.45e-06 | 2 | 36 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 1.45e-06 | 2 | 36 | 2 | C0035934 | |
| Disease | longevity, healthspan, parental longevity | 5.96e-06 | 29 | 36 | 3 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | alopecia areata | 3.14e-05 | 50 | 36 | 3 | EFO_0004192 | |
| Disease | neutrophil percentage of granulocytes | 1.68e-04 | 228 | 36 | 4 | EFO_0007994 | |
| Disease | eosinophil percentage of granulocytes | 1.86e-04 | 234 | 36 | 4 | EFO_0007996 | |
| Disease | basophil count, eosinophil count | 2.08e-04 | 241 | 36 | 4 | EFO_0004842, EFO_0005090 | |
| Disease | allergic disease | 2.70e-04 | 258 | 36 | 4 | MONDO_0005271 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.45e-04 | 152 | 36 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 8.61e-04 | 616 | 36 | 5 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 8.61e-04 | 616 | 36 | 5 | C0376358 | |
| Disease | rheumatoid arthritis, Crohn's disease | 9.90e-04 | 38 | 36 | 2 | EFO_0000384, EFO_0000685 | |
| Disease | Carcinoma, Transitional Cell | 1.15e-03 | 41 | 36 | 2 | C0007138 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QMAHVQIFQRPIQHQ | 1941 | Q09472 | |
| QQHMLPNQAQSPHLQ | 2281 | Q09472 | |
| QQSMTPTQHHQPNLP | 121 | Q99218 | |
| HHHQQMQQAPAPVPQ | 741 | O60885 | |
| PVHLQPMQFSTHIQQ | 996 | O60885 | |
| GKQQMPHHTPHQLQQ | 261 | O75909 | |
| PQQHMLSGQPQASHL | 2316 | Q92793 | |
| PSVQHMLQEQHNQPH | 191 | Q8N7E2 | |
| MLQEQHNQPHKDIQA | 196 | Q8N7E2 | |
| LMHQQPIHPSGSLNQ | 361 | Q9P2D1 | |
| QQQHPVLHLQPQQIM | 411 | Q6ZW49 | |
| PLHIAALNNHPDIMN | 531 | Q96JP0 | |
| LQHRPMGQSQANHIP | 956 | Q5TCQ9 | |
| HENLVEKQHPQQPQV | 66 | Q8NBH2 | |
| PNMPQQRQDQHHQSA | 1001 | Q99700 | |
| NPEQRHHCQQTPNPM | 381 | Q6ZU69 | |
| NPEQRHHCQQTPNPM | 111 | Q63HN1 | |
| ENHGHMPLQPNASLN | 731 | Q14005 | |
| PPSQALPQQLQQMHH | 281 | Q96RN5 | |
| QQQHLHNMPPSALSQ | 351 | Q06413 | |
| PSQQIQMEPIVHIHQ | 326 | Q5T1N1 | |
| PTVQPNMLNVHLLPH | 56 | O00754 | |
| HLQADQLQHKLPQMP | 981 | Q7Z589 | |
| PHLPQHLQDQVQRLM | 496 | Q92902 | |
| HAPLMNIQRNPFNIH | 1236 | Q99590 | |
| QSQIRMFDPEQHPNH | 691 | Q92523 | |
| QQLHSPHQQPLMQQS | 476 | P35680 | |
| NHMSQNHQNIPPTNT | 996 | Q92834 | |
| LHPAAHPPQQNAVMV | 171 | Q9H0F5 | |
| HPPQQNAVMVDIHDQ | 176 | Q9H0F5 | |
| PLVNMHIPENVQHNA | 231 | Q5FBB7 | |
| MQPKHIQAQPQHQDS | 36 | A0A1B0GV85 | |
| HIMNHQCQLKEPSQP | 341 | Q9HCE7 | |
| QFRNLSHNEPHMPQN | 156 | Q99717 | |
| QHLHAIPPTLAMNPQ | 1621 | A5YKK6 | |
| EHVMQPLLHQPSDNQ | 921 | Q15468 | |
| HPPQSPAQIQMQLQH | 1641 | Q86UP3 | |
| HMRKHNPPDLQQQVQ | 451 | Q8TF68 | |
| KTGQPHPHHQQMQQQ | 1551 | Q68DE3 | |
| LQQLQHMQHQSQPSP | 516 | O15405 | |
| NMNLHIPHIQNQIAE | 686 | Q86YA3 | |
| NHNGLLPFHPQNMDL | 101 | O94900 | |
| LQISPPLHQHLNMQQ | 421 | O94900 | |
| PLHQHLNMQQHQPLT | 426 | O94900 | |
| VLDNPHMQQLIQHNP | 191 | Q9H347 | |
| LQEQQQQQMHLQPPS | 336 | Q96PN7 |